United Therapeutics is upgraded to 'Buy', as ralinepag's Phase 3 success de-risks the pipeline and positions UTHR for further upside. Learn more about UTHR stock here.
Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...
Eisai will present lecanemab data focused on real-world efficacy and safety, as well as four-year data from the Clarity AD Open-Label Extension trial. Eisai will also host one industry-sponsored ...
Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results